Occasionally you might notice different side effects on the higher doses that you didnt get with the lower ones, but its rare
In a series of phase 2b trials, berobenatide, an investigational injectable glucagon-like peptide-1 receptor agonist (GLP-1 RA), demonstrated robust weight loss, both in people with obesity or overweight, and in those with obesity or overweight and type 2 diabetes
For Weight Loss For weight loss, semaglutide is often prescribed at higher doses, which can increase the cost
Unlike approved medications, these products havent been reviewed for safety, effectiveness, or quality before hitting the market.
This weight loss injection has shown great results: over 68 weeks, patients taking the drug lost 15-20% of their body weight, compared to 2.4% in patients taking a placebo